me1111
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2013 (NCT01841996)
Timeline
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 2-(3,5-dimethyl-1h-pyrazol-1-yl)-5-methylphenol
- me1111
- me1111
- me1111
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02022215 | Phase 2 | Dec 19, 2013 | Meiji Seika Pharma Co., Ltd. |
| NCT01841996 | Phase 1 | Mar 1, 2013 | Meiji Seika Pharma Co., Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Meiji Seika Pharma Co., Ltd. | For profit | 2 | 2 | 2 | 2013 |
1 organizations
Page 1 / 1